Cargando…
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment
Reference pricing and health technology assessment are policies commonly applied in order to obtain more value for money from pharmaceuticals. This study focussed on decisions about the initial price and reimbursement status of innovative drugs and discussed the consequences for market access and co...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078322/ https://www.ncbi.nlm.nih.gov/pubmed/20803050 http://dx.doi.org/10.1007/s10198-010-0274-y |